IP Library Granted Patent US 8,178,311
Granted Patent B2
US 8,178,311 · App. 12/368,051 · Granted May 15, 2012

Multiple quantification of cholesterol in low density lipoprotein

Assignee: Denka Seiken Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,178,311
App. No.
12/368,051
Granted
May 15, 2012
Kind
B2
Abstract

The present invention is intended to provide a method for simultaneously measuring cholesterol in low density lipoprotein and total cholesterol as test components in blood. Specifically, a method is used for simultaneously measuring cholesterol in low density lipoprotein and total cholesterol in a biological sample, whereby cholesterol in low density lipoprotein and total cholesterol in a biological sample are quantified with a single measurement.

Claims (18)

1. A method for measuring, in one assay, cholesterol in low density lipoprotein and total cholesterol in a biological sample, said method comprising:

(i) introducing in said sample a first reagent that acts on the cholesterol in lipoproteins other than low density lipoprotein to generate a compound, and then measuring the absorbance of said compound; and subsequently

(ii) introducing in the same sample from step (i) a second reagent that acts on at least the low density lipoprotein to generate an additional amount of said compound, and then measuring the elevated absorbance of said compound,

wherein:

(A) the first reagent has a hydrophile-lipophile balance (HLB) value of between 13 or more and 15 or less and the second reagent has an HLB value of between 12 or more and less than 13; and

(B) the value from step (i) represents the amount of cholesterol in lipoprotein other than low density lipoprotein, the value from step (ii) represents the amount of total cholesterol in said sample, and the difference in values from step (i) and step (ii) represents the amount of cholesterol in low density lipoprotein.

2. The method of claim 1 , wherein said first reagent comprises (i) a surfactant that acts only on lipoproteins other than the low density lipoprotein, (ii) cholesterol esterase, and (iii) cholesterol oxidase.

3. The method of claim 2 , wherein said cholesterol esterase is produced by bacteria Pseudomonas.

4. The method of claim 2 , wherein said first reagent further comprises peroxidase, 4-amino antipyrine and a hydrogen donor compound.

5. The method of claim 4 , wherein said hydrogen donor compound is a colored quinone.

6. The method of claim 1 , wherein said first reagent comprises (i) a surfactant that acts only on lipoproteins other than the low density lipoprotein, (ii) cholesterol esterase, and (iii) cholesterol dehydrogenase.

7. The method of claim 6 , wherein said compound is reduced β-nicotinamide adenine dinucleotide.

8. The method of claim 6 , wherein said cholesterol esterase is produced by bacteria Pseudomonas.

9. The method of claim 1 , wherein said second reagent comprises a surfactant that acts on at least the low density lipoprotein.

10. The method of claim 1 , wherein steps (i) and (ii) are carried out in an automated analyzer.

11. The method of claim 1 , wherein step (i) is carried out in the presence of albumin.

12. The method of claim 1 , wherein step (i) is carried out in the presence of lipoprotein lipase.

13. The method of claim 1 , wherein step (i) is carried out in the presence of albumin and lipoprotein lipase.

Assignments (1)
MERGER Recorded Oct 5, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 053976/0705 →
Priority Claims (1)
JP 2002-362970 · Dec 13, 2002 · national
Continuity (2)
Division 10537992
Related Publication 20090197288A1 · Aug 6, 2009